Fineline Cube

Follow:
14433 Articles
Ascletis Pharma Reports Positive Preclinical Results for ASC47 in Obesity Treatment
Others

Ascletis Pharma Reports Positive Preclinical Results for ASC47 in Obesity Treatment

Bayer Collaborates with Kumquat Biosciences to Develop KRAS G12D Inhibitor
CompanyDeals

Bayer Collaborates with Kumquat Biosciences to Develop KRAS G12D Inhibitor

Sino Biopharmaceutical's TQB3142 IND Application Accepted by China's NMPA for Malignant Tumor Treatment
CompanyDrug

Sino Biopharmaceutical’s TQB3142 IND Application Accepted by China’s NMPA for Malignant Tumor Treatment

Novartis' Leqvio Approved by FDA as Standalone Therapy for Hypercholesterolemia
CompanyDrug

Novartis’ Leqvio Approved by FDA as Standalone Therapy for Hypercholesterolemia

HighTide Therapeutics Collaborates with IMB to Assess HTD1801 in T2DM with CKD
CompanyDeals

HighTide Therapeutics Collaborates with IMB to Assess HTD1801 in T2DM with CKD

FDA Launches PreCheck Program to Strengthen U.S. Pharmaceutical Supply Chain
Policy / Regulatory

FDA Launches PreCheck Program to Strengthen U.S. Pharmaceutical Supply Chain

Pfizer Restructures Oncology and Rare Disease Units for Enhanced Focus
Company

Pfizer China Restructures Oncology and Rare Disease Units for Enhanced Focus

China's NHSA Publishes Preliminary List for 2025 National Reimbursement Drug List and Commercial Insurance Innovative Drug List
Policy / Regulatory

China’s NHSA Publishes Preliminary List for 2025 National Reimbursement Drug List and Commercial Insurance Innovative Drug List

Legend Biotech Reports Q2 Revenue Growth of 36.7% and H1 Growth of 60.4%
Company

Legend Biotech Reports Q2 Revenue Growth of 36.7% and H1 Growth of 60.4%

Takeda Reports Q1 FY2025 Revenue Dip Led by FX Headwinds and Generic Competition
Company

Takeda Reports Q1 FY2025 Revenue Dip Led by FX Headwinds and Generic Competition

Hengrui's Trastuzumab Rezetecan and Adebrelimab Granted Breakthrough Therapy Designation by China's NMPA
CompanyDrug

Hengrui’s Trastuzumab Rezetecan and Adebrelimab Granted Breakthrough Therapy Designation by China’s NMPA

Macao Drug Administration Expands White List for Designated Medical Institutions in Cooperation Zone
Policy / Regulatory

Macao Drug Administration Expands White List for Designated Medical Institutions in Cooperation Zone